Price
$5.65
Increased by +5.61%
Dollar volume (20D)
6.56 M
ADR%
4.46
Earnings report date
Aug 1, 2024
Shares float
127.08 M
Shares short
9.21 M [7.24%]
Shares outstanding
143.02 M
Market cap
742.98 M
Beta
1.42
Price/earnings
N/A
20D range
5.11 5.92
50D range
4.71 5.92
200D range
4.71 10.24

Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States.

It offers LUPKYNIS for the treatment of adult patients with active lupus nephritis.

It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company was incorporated in 1993 and is headquartered in Edmonton, Canada.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
Jun 14, 24 -0.03
Increased by +83.33%
-0.14
Increased by +78.57%
Feb 15, 24 -0.19
Decreased by -5.56%
-0.16
Decreased by -18.75%
Nov 2, 23 -0.09
Decreased by -50.00%
-0.17
Increased by +47.06%
Aug 3, 23 -0.08
Increased by +68.00%
-0.18
Increased by +55.56%
May 4, 23 -0.18
Increased by +33.33%
-0.22
Increased by +18.18%
Feb 28, 23 -0.18
Increased by +28.00%
-0.27
Increased by +33.33%
Nov 3, 22 -0.06
Increased by +84.62%
-0.17
Increased by +64.71%
Aug 4, 22 -0.25
Increased by +32.43%
-0.22
Decreased by -13.64%
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Mar 31, 24 50.30 M
Increased by +46.19%
-10.75 M
Increased by +58.98%
Decreased by -21.37%
Increased by +71.94%
Dec 31, 23 45.09 M
Increased by +58.59%
-26.88 M
Decreased by -3.18%
Decreased by -59.60%
Increased by +34.94%
Sep 30, 23 54.52 M
Decreased by -2.27%
-13.45 M
Decreased by -49.59%
Decreased by -24.67%
Decreased by -53.06%
Jun 30, 23 41.49 M
Increased by +47.19%
-11.49 M
Increased by +67.64%
Decreased by -27.70%
Increased by +78.02%
Mar 31, 23 34.41 M
Increased by +59.12%
-26.21 M
Increased by +30.36%
Decreased by -76.16%
Increased by +56.23%
Dec 31, 22 28.43 M
Increased by +21.50%
-26.05 M
Increased by +21.84%
Decreased by -91.60%
Increased by +35.67%
Sep 30, 22 55.78 M
Increased by +280.30%
-8.99 M
Increased by +82.11%
Decreased by -16.12%
Increased by +95.30%
Jun 30, 22 28.19 M
Increased by +325.85%
-35.52 M
Increased by +24.45%
Decreased by -125.98%
Increased by +82.26%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY